Patents by Inventor Radwan S. Elhaggar
Radwan S. Elhaggar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11312694Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: GrantFiled: September 24, 2021Date of Patent: April 26, 2022Assignee: King Abdulaziz UniversityInventors: Moustafa E. El-Araby, Abdelsattar M. Omar, Martin K. Safo, Radwan S. Elhaggar, Tamer M. Abdelghany, Mostafa H. Ahmed
-
Publication number: 20220033368Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: ApplicationFiled: September 24, 2021Publication date: February 3, 2022Applicant: King Abdulaziz UniversityInventors: Moustafa E. EL-ARABY, Abdelsattar M. OMAR, Martin K. SAFO, Radwan S. ELHAGGAR, Tamer M. ABDELGHANY, Mostafa H. AHMED
-
Publication number: 20220009896Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: ApplicationFiled: September 24, 2021Publication date: January 13, 2022Applicant: King Abdulaziz UniversityInventors: Moustafa E. EL-ARABY, Abdelsattar M. OMAR, Martin K. SAFO, Radwan S. ELHAGGAR, Tamer M. ABDELGHANY, Mostafa H. AHMED
-
Patent number: 11214556Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: GrantFiled: September 24, 2021Date of Patent: January 4, 2022Assignee: King Abdulaziz UniversityInventors: Moustafa E. El-Araby, Abdelsattar M. Omar, Martin K. Safo, Radwan S. Elhaggar, Tamer M. Abdelghany, Mostafa H. Ahmed
-
Patent number: 11155528Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: GrantFiled: October 25, 2019Date of Patent: October 26, 2021Assignee: King Abdulaziz UniversityInventors: Moustafa E. El-Araby, Abdelsattar M. Omar, Martin K. Safo, Radwan S. Elhaggar, Tamer M. Abdelghany, Mostafa H. Ahmed
-
Publication number: 20210122721Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: ApplicationFiled: October 25, 2019Publication date: April 29, 2021Applicant: King Abdulaziz UniversityInventors: Moustafa E. EL-ARABY, Abdelsattar M. OMAR, Martin K. SAFO, Radwan S. ELHAGGAR, Tamer M. ABDELGHANY, Mostafa H. AHMED
-
Patent number: 10836736Abstract: A compound of formula (I), wherein R1 is an optionally substituted aryl or an optionally substituted heteroaryl, R2 is an optionally substituted aryl or an optionally substituted heteroaryl, and R3 is an optionally substituted alkylamino, an optionally substituted cycloalkylamino, an optionally substituted arylamino, an optionally substituted heterocyclylamino, an optionally substituted heterocyclyl, and an optionally substituted dialkylamino. A pharmaceutical composition which includes the compound of formula (I) and a pharmaceutically acceptable carrier and/or excipient. A method of treating colorectal cancer in a subject, whereby a therapeutically effective amount of the compound of formula (I) is administered to the subject.Type: GrantFiled: August 5, 2020Date of Patent: November 17, 2020Assignee: King Abdulaziz UniversityInventors: Moustafa E. El-Araby, Abdelsattar M. Omar, Martin K. Safo, Radwan S. Elhaggar, Tamer M. Abdelghany, Mostafa H. Ahmed